Pharmaceuticals Projects in India – Page 231

1,542 upcoming and ongoing pharmaceuticals projects in India worth ₹665,172 Cr, with investment, location, project stage and latest status. Last updated 08 Oct 2026.

Projects tracked
1,542
Total investment
₹665,172 Cr
Projects above ₹100 Cr
281
Added in the last 30 days
10

Latest pharmaceuticals projects in India

Showing 1,151–1,155 of 1,542
  1. Under Implementation Pharmaceuticals Projects Updated

    API Intermediates Expansion Project in Palghar, Maharashtra

    Maharashtra Less than 100 Million

    A pharmaceutical firm in Maharashtra plans a Rs. 66.082 million API intermediates expansion in Tarapur, aiming to boost production capacity to 658 TPM. In progress since July 2020, it's actively seeking final environmental clearance, emphasizing responsible manufacturing practices.

    View project
  2. Environment Clearance Stage Pharmaceuticals Projects Updated

    New Bulk Drug and its Intermediates Mfg. Project in Andhra Pradesh

    Andhra Pradesh NA

    A bulk drug and intermediates manufacturing project in Andhra Pradesh aims to produce 100 TPM, with an estimated cost of Rs. 1,349 million. Environmental clearance was underway as of August 2017, and the project is in the development stage as of September 2020, emphasizing responsible pharmaceutical manufacturing.

    View project
  3. Project Work Commenced Pharmaceuticals Projects Updated

    Rs.311 Million Pharma Products Expansion Project in Solan, Himachal Pradesh

    Himachal Pradesh From 100 Million to 999 Million

    A pharma expansion project in Himachal Pradesh aims to boost medicated cream production from 15 to 20 lakhs units, with an estimated cost of Rs. 311.6 million. Approved by the State Level Single Window Clearance Committee in September 2020.

    View project
  4. Project Work Commenced Pharmaceuticals Projects Updated

    Rs.252 Million New Pharma Products Mfg. Unit in Solan Himachal Pradesh

    Himachal Pradesh From 100 Million to 999 Million

    In Himachal Pradesh's Thana Baddi, Prosperity 6 Pharmaceutics (Unit-II) is launching a new Pharma Products Manufacturing Unit, with a focus on producing Piperacillin Tazobactam (18 million units/year), at an estimated cost of Rs. 252.472 million. The project received approval from the State Single Window Clearance & Monitoring Authority in August 2020 and has commenced work as of September 2020. This endeavor underscores the commitment to pharmaceutical excellence and healthcare advancement in the region.

    View project